Legend Biotech(LEGN) - 2024 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________ FORM 6-K ________________________________ Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 Date of Report: November 12, 2024 Commission File Number: 001-39307 ________________________________ Legend Biotech Corporation | --- | |---------------------------------------------------------------------------------------------------| | | | | | (Exact Name ...